SOLICITATION NOTICE
66 -- Purchase of an Illumina NeoPrep Library Prep System
- Notice Date
- 8/9/2015
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02RC52681-83
- Archive Date
- 9/9/2015
- Point of Contact
- Gwennifer K. Epps, Phone: 240-276-5445, Terry Galloway, Phone: 240-276-5384
- E-Mail Address
-
eppsg@mail.nih.gov, gallowaytl@mail.nih.gov
(eppsg@mail.nih.gov, gallowaytl@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Center for Cancer Research (CCR), Genetics Branch on a sole source basis plans to purchase a Illumina Prep Library Prep System from Illumina Inc., 5200 Illumina Way, San Diego CA 92122. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1 (b)(2) and 13.501-(a)(1) using simplified acquisition procedures for commercial acquisitions. The Government contemplates only one award of a Firm-Fixed Price contract. The Associated North America Industry Classification Code (NAICS) 334516 and the Business Size Standard is 500 employees. It has been determined there are no opportunities to acquire green products or services for this procurement. The delivery of the equipment is due no later than 60 days from award of the contract. The Genetics Branch (GB) is one that underlies its basic research focus and others that form the foundation of its clinical and translational research activities. The concept that underlies basic research is that cancer is a genetic disease caused by genetic instability. Thus, the GB of the CCR at the National Cancer Institute is engaged in the study of cancer genetics. Investigating genetics alteration and its effect on the development and biology of cancer is an integral function of the Genetics Branch. By using ultra-high throughput methods, in conjunction with next generation sequencing NCI will be able to reveal aspects of cancer biology not possible using more conventional methods. Preparation of strand-specific Illumina RNA-Seq libraries is a highly demanding process that currently requires excessive hands on time and is prone to human error. Additionally, when libraries are prepared manually, it is incredibly challenging to normalize the concentration across a set of libraries so that they may be pooled and run in parallel yielding sufficient data. The GB, currently require a digital microfluidic based instrument, which allows 16 or more RNA samples to be prepared into strand-specific Illumina RNA-Seq libraries, completely unattended, without manual intervention. The instrument must also have an automated normalization step, that will pool libraries for equal loading on the four Government owned Illumina NGS sequencers. Therefore, as a sole source, the NCI intends to procure a Illumina NeoPrep Library Prep System from Illumina for Sequencing tumor RNA from patients using Next Generation Sequencing. The NeoPrep system is compatible with the Government owned Illumina NGS sequencers. The machine is also a digital microfluidic based instrument, which allows 16 or more RNA samples to be prepared into strand-specific Illumina RNA-Seq libraries, completely unattended, without manual intervention; automatically accomplishes a normalization step that pools libraries for equal loading on Government owned Illumina NGS sequencers. To the NCI's knowledge, there is no other known, digital microfluidic instrument on the market that meets these requirements of unattended throughput and normalization of strand-specific Illumina RNA-Seq libraries. Due to the nature and complexity of the instrument, the original manufacturer (OEM) is the only vendor qualified to provide this system. This is not a solicitation for competitive quotations. However, if any interested party especially a small business, believes they can meet the above requirement, may submit a quote and statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. All questions, quote, and the capability statement must be received electronically (via email) to Ms. Gwennifer Epps, Contracting Officer, at ge50d@nih.gov in MS Word or Adobe Portable Document Format (PDF) by August 25, 2015 no later than 11:00 AM EST. No telephone calls or facsimiles will be accepted. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA), through sam.gov. No collect calls will be accepted. Please reference solicitation number N02RC52681-83 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02RC52681-83 /listing.html)
- Place of Performance
- Address: National Cancer Institute, NIH - Genetics Branch, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03830182-W 20150811/150809233349-bd39663b8b4b495b3bdd67bfd7e15e2e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |